Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure (Q35771932)
Jump to navigation
Jump to search
scientific article published on 21 April 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure |
scientific article published on 21 April 2005 |
Statements
Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure (English)
A Kardos
C H Davies
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference